JB Pharma
Pharmaceuticals with leadership in key therapeutic categories, focusing on affordability, accessibility, and CDMO opportunities in lozenges.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | INR119.2b Valuation: INR256.9b | Acquisition | |
| Total Funding | 000k | ||
JB Pharma is a pharmaceutical entity with a significant presence in the Indian domestic market, holding five brands within the top 300 domestic formulation brands. The company has established leadership in its chosen therapeutic categories through a strategy of incremental innovation and product life cycle management.
Its business model centers on making high-quality drugs both affordable and accessible, distributing its products through a vast network of approximately 600,000 pharmacies across India. The company's revenue streams are derived from its portfolio of pharmaceutical brands, with a particular focus on chronic therapies.
In addition to its branded formulations, JB Pharma is exploring Contract Development and Manufacturing Organization (CDMO) opportunities, specifically within the lozenges segment. The organization emphasizes robust processes for product safety and consumer complaint resolution, which extend beyond standard regulatory requirements.
Keywords: pharmaceuticals, drug delivery, therapeutic categories, life cycle management, CDMO, lozenges, Indian market, chronic portfolio, drug formulation, accessible healthcare